Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Victor Fujimoto, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentObGyn, Reproductive Sciences
    Address2356 Sutter St., MZ Bldg J
    San Francisco CA 94143

       Biography 
       Education and Training
      Institution Degree School or Department Year
      University of California, San FranciscoPost-Doc Fellow/Scholar Medicine (Obstetrics & Gynecology)2003
      University of California, San FranciscoPost-Doc Fellow/Scholar Medicine (Obstetrics & Gynecology)1991
      University of California San DiegoM.D.School of Medicine1986

       Overview 
       Overview
      Dr. Victor Fujimoto received his medical degree from the University of California at San Diego. He completed his residency at the Mayo Graduate School and fellowship training at UCSF. He practiced Reproductive Endocrinology and Infertility at the University of Washington from 1993-2000. Dr. Fujimoto is board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility. He has been practicing reproductive medicine since 1990. He serves as an Advisory Board member of the Institute of Biogenesis Research at the University of Hawaii, Manoa, HI. He has previously served on the board of Northern California RESOLVE, a non-profit patient advocacy organization.

      His clinical and research interests include all aspects of IVF technologies. He is actively involved in investigating the origins and biology of human embryo fragmentation seen during IVF. His research in this area has uncovered several factors involving high density lipoprotein (HDL) particles as being pivotal in the development of human embryo fragmentation. He was recently funded by the NIH to unravel the mystery of human embryo fragmentation in vitro so that future treatment approaches can be developed to overcome this problem. Another area of research interest for Dr. Fujimoto is the impact of environmental contaminants on human reproduction. Specifically, the effects of toxic metals such as mercury, lead and cadmium on IVF outcomes is currently being investigated as are organic contaminants such as bisphenol A (BPA), a meiotic disruptor in various animal studies. He also has an interest in understanding the factors that influence IVF pregnancy rates such as Asian ethnicity.

      "As a former infertility patient myself, I look toward my profession with greater compassion and awareness of the emotional pain and suffering that many couples go through. I believe that it is this awareness that makes my work so rewarding as an infertility specialist assisting couples achieve pregnancy. I strongly believe that couples need to understand their reproductive potential and how it affects their reproductive choices."


       ORNG Applications 
       Websites
       In The News
       NIH Grants Awarded
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kim K, Bloom MS, Kruger PC, Parsons PJ, Arnason JG, Byun Y, Goins S, Fujimoto VY. Toxic metals in seminal plasma and in vitro fertilization (IVF) outcomes. Environ Res. 2014 Aug; 133:334-7.
        View in: PubMed
      2. Kim K, Bloom MS, Fujimoto VY, Browne RW. Number of specimens required to estimate average follicular fluid high-density lipoprotein particle components in women undergoing in vitro fertilization. Fertil Steril. 2014 Jun; 101(6):e44.
        View in: PubMed
      3. Lathi RB, Liebert CA, Brookfield KF, Taylor JA, Vom Saal FS, Fujimoto VY, Baker VL. Conjugated bisphenol A in maternal serum in relation to miscarriage risk. Fertil Steril. 2014 Jul; 102(1):123-8.
        View in: PubMed
      4. Bloom MS, Kim K, Fujimoto VY, Browne RW. Variability in the components of high-density lipoprotein particles measured in human ovarian follicular fluid: a cross-sectional analysis. Fertil Steril. 2014 May; 101(5):1431-1440.e5.
        View in: PubMed
      5. Gerona RR, Woodruff TJ, Dickenson CA, Pan J, Schwartz JM, Sen S, Friesen MW, Fujimoto VY, Hunt PA. Bisphenol-A (BPA), BPA Glucuronide, and BPA Sulfate in Midgestation Umbilical Cord Serum in a Northern and Central California Population. Environ Sci Technol. 2013 Nov 5; 47(21):12477-85.
        View in: PubMed
      6. Spitzer T, Fujimoto VY. Ethnic differences in assisted reproductive technologies outcomes. Semin Reprod Med. 2013 Sep; 31(5):360-4.
        View in: PubMed
      7. Buck Louis GM, Peterson CM, Chen Z, Croughan M, Sundaram R, Stanford J, Varner MW, Kennedy A, Giudice L, Fujimoto VY, Sun L, Wang L, Guo Y, Kannan K. Bisphenol A and phthalates and endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study. Fertil Steril. 2013 Jul; 100(1):162-9.e1-2.
        View in: PubMed
      8. Kim D, Bloom MS, Parsons PJ, Fitzgerald EF, Bell EM, Steuerwald AJ, Fujimoto VY. A pilot study of seafood consumption and exposure to mercury, lead, cadmium and arsenic among infertile couples undergoing in vitro fertilization (IVF). Environ Toxicol Pharmacol. 2013 Jul; 36(1):30-4.
        View in: PubMed
      9. Peterson CM, Johnstone EB, Hammoud AO, Stanford JB, Varner MW, Kennedy A, Chen Z, Sun L, Fujimoto VY, Hediger ML, Buck Louis GM. Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study. Am J Obstet Gynecol. 2013 Jun; 208(6):451.e1-11.
        View in: PubMed
      10. Bloom MS, Kim K, Kruger PC, Parsons PJ, Arnason JG, Steuerwald AJ, Fujimoto VY. Associations between toxic metals in follicular fluid and in vitro fertilization (IVF) outcomes. J Assist Reprod Genet. 2012 Dec; 29(12):1369-79.
        View in: PubMed
      11. Louis GM, Peterson CM, Chen Z, Hediger ML, Croughan MS, Sundaram R, Stanford JB, Fujimoto VY, Varner MW, Giudice LC, Kennedy A, Sun L, Wu Q, Kannan K. Perfluorochemicals and endometriosis: the ENDO study. Epidemiology. 2012 Nov; 23(6):799-805.
        View in: PubMed
      12. Cakmak H, Fujimoto VY, Zamah AM, Rosen MP, Tran ND, Cedars MI, Rinaudo PF. Metaphase II (MII) oocytes obtained at different time points in the same in vitro fertilization cycle. J Assist Reprod Genet. 2012 Nov; 29(11):1203-5.
        View in: PubMed
      13. Gianetti E, Hall JE, Au MG, Kaiser UB, Quinton R, Stewart JA, Metzger DL, Pitteloud N, Mericq V, Merino PM, Levitsky LL, Izatt L, Lang-Muritano M, Fujimoto VY, Dluhy RG, Chase ML, Crowley WF, Plummer L, Seminara SB. When genetic load does not correlate with phenotypic spectrum: lessons from the GnRH receptor (GNRHR). J Clin Endocrinol Metab. 2012 Sep; 97(9):E1798-807.
        View in: PubMed
      14. Bloom MS, Fujimoto VY, Steuerwald AJ, Cheng G, Browne RW, Parsons PJ. Background exposure to toxic metals in women adversely influences pregnancy during in vitro fertilization (IVF). Reprod Toxicol. 2012 Nov; 34(3):471-81.
        View in: PubMed
      15. Wellons MF, Fujimoto VY, Baker VL, Barrington DS, Broomfield D, Catherino WH, Richard-Davis G, Ryan M, Thornton K, Armstrong AY. Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes. Fertil Steril. 2012 Aug; 98(2):406-9.
        View in: PubMed
      16. Buck Louis GM, Chen Z, Peterson CM, Hediger ML, Croughan MS, Sundaram R, Stanford JB, Varner MW, Fujimoto VY, Giudice LC, Trumble A, Parsons PJ, Kannan K. Persistent lipophilic environmental chemicals and endometriosis: the ENDO Study. Environ Health Perspect. 2012 Jun; 120(6):811-6.
        View in: PubMed
      17. Hanna CW, Bloom MS, Robinson WP, Kim D, Parsons PJ, vom Saal FS, Taylor JA, Steuerwald AJ, Fujimoto VY. DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Hum Reprod. 2012 May; 27(5):1401-10.
        View in: PubMed
      18. Fujimoto VY, Bloom MS, Huddleston HG, Shelley WB, Ocque AJ, Browne RW. Correlations of follicular fluid oxidative stress biomarkers and enzyme activities with embryo morphology parameters during in vitro fertilization. Fertil Steril. 2011 Dec; 96(6):1357-61.
        View in: PubMed
      19. Bloom MS, Kim D, Vom Saal FS, Taylor JA, Cheng G, Lamb JD, Fujimoto VY. Bisphenol A exposure reduces the estradiol response to gonadotropin stimulation during in vitro fertilization. Fertil Steril. 2011 Sep; 96(3):672-677.e2.
        View in: PubMed
      20. Huddleston HG, Rosen MP, Gibson M, Cedars MI, Fujimoto VY. Ethnic variation in estradiol metabolism in reproductive age Asian and white women treated with transdermal estradiol. Fertil Steril. 2011 Sep; 96(3):797-9.
        View in: PubMed
      21. Kim K, Steuerwald AJ, Parsons PJ, Fujimoto VY, Browne RW, Bloom MS. Biomonitoring for exposure to multiple trace elements via analysis of urine from participants in the study of metals and assisted reproductive technologies (SMART). J Environ Monit. 2011 Sep; 13(9):2413-9.
        View in: PubMed
      22. Bloom MS, Vom Saal FS, Kim D, Taylor JA, Lamb JD, Fujimoto VY. Serum unconjugated bisphenol A concentrations in men may influence embryo quality indicators during in vitro fertilization. Environ Toxicol Pharmacol. 2011 Sep; 32(2):319-23.
        View in: PubMed
      23. Buck Louis GM, Hediger ML, Peterson CM, Croughan M, Sundaram R, Stanford J, Chen Z, Fujimoto VY, Varner MW, Trumble A, Giudice LC. Incidence of endometriosis by study population and diagnostic method: the ENDO study. Fertil Steril. 2011 Aug; 96(2):360-5.
        View in: PubMed
      24. Wang ET, Fujimoto VY, Yeaton-Massey AJ, Vittinghoff E, Caughey AB, Huddleston HG. Asian ethnicity and fecundability in women with spontaneous conceptions. Fertil Steril. 2011 Jun 30; 95(8):2769-71.
        View in: PubMed
      25. Sharma H, Johnstone EB, Gates E, Sohn SH, Huddleston HG, Fujimoto VY. Asian immigrants to the United States are less likely to donate cryopreserved embryos for research use. Fertil Steril. 2011 Apr; 95(5):1672-6.
        View in: PubMed
      26. Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Racial and ethnic disparities in assisted reproductive technology pregnancy and live birth rates within body mass index categories. Fertil Steril. 2011 Apr; 95(5):1661-6.
        View in: PubMed
      27. Fujimoto VY, Browne RW, Bloom MS, Sakkas D, Alikani M. Pathogenesis, developmental consequences, and clinical correlations of human embryo fragmentation. Fertil Steril. 2011 Mar 15; 95(4):1197-204.
        View in: PubMed
      28. Fujimoto VY, Kim D, vom Saal FS, Lamb JD, Taylor JA, Bloom MS. Serum unconjugated bisphenol A concentrations in women may adversely influence oocyte quality during in vitro fertilization. Fertil Steril. 2011 Apr; 95(5):1816-9.
        View in: PubMed
      29. Bloom MS, Parsons PJ, Kim D, Steuerwald AJ, Vaccari S, Cheng G, Fujimoto VY. Toxic trace metals and embryo quality indicators during in vitro fertilization (IVF). Reprod Toxicol. 2011 Feb; 31(2):164-70.
        View in: PubMed
      30. Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod. 2011 Jan; 26(1):245-52.
        View in: PubMed
      31. Kim K, Fujimoto VY, Parsons PJ, Steuerwald AJ, Browne RW, Bloom MS. Recent cadmium exposure among male partners may affect oocyte fertilization during in vitro fertilization (IVF). J Assist Reprod Genet. 2010 Aug; 27(8):463-8.
        View in: PubMed
      32. Csokmay JM, Hill MJ, Maguire M, Payson MD, Fujimoto VY, Armstrong AY. Are there ethnic differences in pregnancy rates in African-American versus white women undergoing frozen blastocyst transfers? Fertil Steril. 2011 Jan; 95(1):89-93.
        View in: PubMed
      33. Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol. 2010 Jun; 202(6):514-21.
        View in: PubMed
      34. Huddleston HG, Cedars MI, Sohn SH, Giudice LC, Fujimoto VY. Racial and ethnic disparities in reproductive endocrinology and infertility. Am J Obstet Gynecol. 2010 May; 202(5):413-9.
        View in: PubMed
      35. Langen ES, Shahine LK, Lamb JD, Lathi RB, Milki AA, Fujimoto VY, Westphal LM. Asian ethnicity and poor outcomes after in vitro fertilization blastocyst transfer. Obstet Gynecol. 2010 Mar; 115(3):591-6.
        View in: PubMed
      36. Dehlendorf C, Bryant AS, Huddleston HG, Jacoby VL, Fujimoto VY. Health disparities: definitions and measurements. Am J Obstet Gynecol. 2010 Mar; 202(3):212-3.
        View in: PubMed
      37. Fujimoto VY, Jain T, Alvero R, Nelson LM, Catherino WH, Olatinwo M, Marsh EE, Broomfield D, Taylor H, Armstrong AY. Proceedings from the conference on Reproductive Problems in Women of Color. Fertil Steril. 2010 Jun; 94(1):7-10.
        View in: PubMed
      38. Bloom MS, Parsons PJ, Steuerwald AJ, Schisterman EF, Browne RW, Kim K, Coccaro GA, Conti GC, Narayan N, Fujimoto VY. Toxic trace metals and human oocytes during in vitro fertilization (IVF). Reprod Toxicol. 2010 Jun; 29(3):298-305.
        View in: PubMed
      39. Huddleston HG, Rosen MP, Lamb JD, Modan A, Cedars MI, Fujimoto VY. Asian ethnicity in anonymous oocyte donors is associated with increased estradiol levels but comparable recipient pregnancy rates compared with Caucasians. Fertil Steril. 2010 Nov; 94(6):2059-63.
        View in: PubMed
      40. Fujimoto VY, Kane JP, Ishida BY, Bloom MS, Browne RW. High-density lipoprotein metabolism and the human embryo. Hum Reprod Update. 2010 Jan-Feb; 16(1):20-38.
        View in: PubMed
      41. Browne RW, Bloom MS, Shelly WB, Ocque AJ, Huddleston HG, Fujimoto VY. Follicular fluid high density lipoprotein-associated micronutrient levels are associated with embryo fragmentation during IVF. J Assist Reprod Genet. 2009 Nov-Dec; 26(11-12):557-60.
        View in: PubMed
      42. Johnstone E, Sandler JR, Addauan-Andersen C, Sohn SH, Fujimoto VY. Asian women are less likely to express interest in infertility research. Fertil Steril. 2010 Sep; 94(4):1249-53.
        View in: PubMed
      43. Cheng EY, Hunt PA, Naluai-Cecchini TA, Fligner CL, Fujimoto VY, Pasternack TL, Schwartz JM, Steinauer JE, Woodruff TJ, Cherry SM, Hansen TA, Vallente RU, Broman KW, Hassold TJ. Meiotic recombination in human oocytes. PLoS Genet. 2009 Sep; 5(9):e1000661.
        View in: PubMed
      44. Lamb JD, Huddleston HG, Purcell KJ, Modan A, Farsani TT, Dingeldein MA, Vittinghoff E, Fujimoto VY. Asian ethnicity is associated with decreased pregnancy rates following intrauterine insemination. Reprod Biomed Online. 2009 Aug; 19(2):252-6.
        View in: PubMed
      45. Fujimoto VY, Luke B, Brown MB, Jain T, Armstrong A, Grainger DA, Hornstein MD. Racial and ethnic disparities in assisted reproductive technology outcomes in the United States. Fertil Steril. 2010 Feb; 93(2):382-90.
        View in: PubMed
      46. Browne RW, Shelly WB, Bloom MS, Ocque AJ, Sandler JR, Huddleston HG, Fujimoto VY. Distributions of high-density lipoprotein particle components in human follicular fluid and sera and their associations with embryo morphology parameters during IVF. Hum Reprod. 2008 Aug; 23(8):1884-94.
        View in: PubMed
      47. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008 Apr; 198(4):357-66.
        View in: PubMed
      48. Baker VL, Fujimoto VY, Kettel LM, Adamson GD, Hoehler F, Jones CE, Soules MR. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial. Fertil Steril. 2009 Apr; 91(4):1005-11.
        View in: PubMed
      49. Purcell KJ, Schembri M, Telles TL, Fujimoto VY, Cedars MI. Bed rest after embryo transfer: a randomized controlled trial. Fertil Steril. 2007 Jun; 87(6):1322-6.
        View in: PubMed
      50. Purcell K, Schembri M, Frazier LM, Rall MJ, Shen S, Croughan M, Grainger DA, Fujimoto VY. Asian ethnicity is associated with reduced pregnancy outcomes after assisted reproductive technology. Fertil Steril. 2007 Feb; 87(2):297-302.
        View in: PubMed
      51. Klatsky PC, Lane DE, Ryan IP, Fujimoto VY. The effect of fibroids without cavity involvement on ART outcomes independent of ovarian age. Hum Reprod. 2007 Feb; 22(2):521-6.
        View in: PubMed
      52. Shen S, Rosen MP, Dobson AT, Fujimoto VY, McCulloch CE, Cedars MI. Day 2 transfer improves pregnancy outcome in in vitro fertilization cycles with few available embryos. Fertil Steril. 2006 Jul; 86(1):44-50.
        View in: PubMed
      53. Lane DE, Vittinghoff E, Croughan MS, Cedars MI, Fujimoto VY. Gonadotropin stimulation demonstrates a ceiling effect on in vitro fertilization outcomes. Fertil Steril. 2006 Jun; 85(6):1708-13.
        View in: PubMed
      54. Rosen MP, Shen S, Dobson AT, Fujimoto VY, McCulloch CE, Cedars MI. Oocyte degeneration after intracytoplasmic sperm injection: a multivariate analysis to assess its importance as a laboratory or clinical marker. Fertil Steril. 2006 Jun; 85(6):1736-43.
        View in: PubMed
      55. Rosen MP, Shen S, Dobson AT, Fujimoto VY, McCulloch CE, Cedars MI. Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation. Fertil Steril. 2006 Feb; 85(2):384-90.
        View in: PubMed
      56. Chan AH, Fujimoto VY, Moore DE, Held RT, Paun M, Vaezy S. In vivo feasibility of image-guided transvaginal focused ultrasound therapy for the treatment of intracavitary fibroids. Fertil Steril. 2004 Sep; 82(3):723-30.
        View in: PubMed
      57. Keshavarzi A, Vaezy S, Noble ML, Paun MK, Fujimoto VY. Treatment of uterine fibroid tumors in an in situ rat model using high-intensity focused ultrasound. Fertil Steril. 2003 Sep; 80 Suppl 2:761-7.
        View in: PubMed
      58. Paek BW, Vaezy S, Fujimoto V, Bailey M, Albanese CT, Harrison MR, Farmer DL. Tissue ablation using high-intensity focused ultrasound in the fetal sheep model: potential for fetal treatment. Am J Obstet Gynecol. 2003 Sep; 189(3):702-5.
        View in: PubMed
      59. Chan AH, Fujimoto VY, Moore DE, Martin RW, Vaezy S. An image-guided high intensity focused ultrasound device for uterine fibroids treatment. Med Phys. 2002 Nov; 29(11):2611-20.
        View in: PubMed
      60. Keshavarzi A, Vaezy S, Noble ML, Chi EY, Walker C, Martin RW, Fujimoto VY. Treatment of uterine leiomyosarcoma in a xenograft nude mouse model using high-intensity focused ultrasound: a potential treatment modality for recurrent pelvic disease. Gynecol Oncol. 2002 Sep; 86(3):344-50.
        View in: PubMed
      61. Houmard BS, Juang MP, Soules MR, Fujimoto VY. Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment. Fertil Steril. 2002 Feb; 77(2):384-6.
        View in: PubMed
      62. Keshavarzi A, Vaezy S, Kaczkowski PJ, Keilman G, Martin R, Chi EY, Garcia R, Fujimoto VY. Attenuation coefficient and sound speed in human myometrium and uterine fibroid tumors. J Ultrasound Med. 2001 May; 20(5):473-80.
        View in: PubMed
      63. Moore DE, Soules MR, Klein NA, Fujimoto VY, Agnew KJ, Eschenbach DA. Bacteria in the transfer catheter tip influence the live-birth rate after in vitro fertilization. Fertil Steril. 2000 Dec; 74(6):1118-24.
        View in: PubMed
      64. Vaezy S, Fujimoto VY, Walker C, Martin RW, Chi EY, Crum LA. Treatment of uterine fibroid tumors in a nude mouse model using high-intensity focused ultrasound. Am J Obstet Gynecol. 2000 Jul; 183(1):6-11.
        View in: PubMed
      65. Fujimoto VY, Klein NA, Miller PB. Late-onset hematometra and hematosalpinx in a woman with a noncommunicating uterine horn. A case report. J Reprod Med. 1998 May; 43(5):465-7.
        View in: PubMed
      66. Cataldo NA, Fujimoto VY, Jaffe RB. Interferon-gamma and activin A promote insulin-like growth factor-binding protein-2 and -4 accumulation by human luteinizing granulosa cells, and interferon-gamma promotes their apoptosis. J Clin Endocrinol Metab. 1998 Jan; 83(1):179-86.
        View in: PubMed
      67. Fujimoto VY, Miller JH, Klein NA, Soules MR. Congenital cervical atresia: report of seven cases and review of the literature. Am J Obstet Gynecol. 1997 Dec; 177(6):1419-25.
        View in: PubMed
      68. Kim YK, Wasser SK, Fujimoto VY, Klein NA, Moore DE, Soules MR. Utility of follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol and FSH:LH ratio in predicting reproductive age in normal women. Hum Reprod. 1997 Jun; 12(6):1152-5.
        View in: PubMed
      69. Fujimoto VY, Monroe SE, Nelson LR, Downey D, Jaffe RB. Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray. Fertil Steril. 1997 Mar; 67(3):469-73.
        View in: PubMed
      70. Fujimoto VY, Klein NA, Battaglia DE, Bremner WJ, Soules MR. The anterior pituitary response to a gonadotropin-releasing hormone challenge test in normal older reproductive-age women. Fertil Steril. 1996 Mar; 65(3):539-44.
        View in: PubMed
      71. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab. 1996 Mar; 81(3):1038-45.
        View in: PubMed
      72. Mesiano S, Fujimoto VY, Nelson LR, Lee JY, Voytek CC, Jaffe RB. Localization and regulation of corticotropin receptor expression in the midgestation human fetal adrenal cortex: implications for in utero homeostasis. J Clin Endocrinol Metab. 1996 Jan; 81(1):340-5.
        View in: PubMed
      73. Nelson LR, Fujimoto VY, Jaffe RB, Monroe SE. Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix). Fertil Steril. 1995 May; 63(5):963-9.
        View in: PubMed
      74. Cataldo NA, Fujimoto VY, Jaffe RB. Activin-A stimulates the expression of insulin-like growth factor binding protein-5 messenger RNA in human luteinizing granulosa cells. Recent Prog Horm Res. 1995; 50:437-42.
        View in: PubMed
      75. Cataldo NA, Rabinovici J, Fujimoto VY, Jaffe RB. Follistatin antagonizes the effects of activin-A on steroidogenesis in human luteinizing granulosa cells. J Clin Endocrinol Metab. 1994 Jul; 79(1):272-7.
        View in: PubMed
      76. Fujimoto VY, Spencer SJ, Rabinovici J, Plosker S, Jaffe RB. Endogenous catecholamines augment the inhibitory effect of opioids on luteinizing hormone secretion during the midluteal phase. Am J Obstet Gynecol. 1993 Dec; 169(6):1524-30.
        View in: PubMed
      77. Fujimoto VY, Clifton DK, Cohen NL, Soules MR. Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting. Obstet Gynecol. 1990 Jul; 76(1):71-8.
        View in: PubMed
      78. Patton PE, Calvo FO, Fujimoto VY, Bergert ER, Kempers RD, Ryan RJ. The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women. Fertil Steril. 1988 Apr; 49(4):620-5.
        View in: PubMed
      79. Fujimoto VY, Villanueva AL, Hopper B, Moscinski M, Rebar RW. Increased adrenocortical responsiveness to exogenous ACTH in oral contraceptive users. Adv Contracept. 1986 Dec; 2(4):343-53.
        View in: PubMed
      Victor's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP